CED Cannabis Science Digest: Pregnancy Risk Perception Signals
This digest highlights pregnancy safety beliefs cannabis signals from recent studies. It covers U.S. survey data on pregnancy risk perception and cannabis use trends among women of childbearing age. Additionally, it examines cannabis expectancies among…
VA Documents Show How Veterans’ Cannabis Access Could Expand—And What Will Stay …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyVeteransPainAnxietyMental HealthSafetyResearch Why This Matters Understanding how the VA’s cannabis…
Congress considers veterans’ medical cannabis amendment (Newsletter: May 8, 2026)
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyMental HealthResearchSafety Why This Matters If Congress passes a veterans’ medical cannabis amendment, it…
Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health
Utah has passed legislation enabling psychedelic-assisted therapy veterans clinical trials for treatment-resistant mental health conditions. This policy supports research on PTSD and depression in veterans. The new law may expand treatment options beyond…
Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine
Ibogaine addiction treatment is gaining attention due to emerging psychedelic research and political interest. This article discusses the clinical evidence and safety protocols surrounding ibogaine. Understanding ibogaine's potential and risks is…
White House Advances Psychedelic and Cannabis Research for Veterans
The 2026 cannabis psychedelic research initiative accelerates federal studies on veteran PTSD and trauma. This policy shift supports clinical trials to better understand cannabis benefits. Clinicians can expect new evidence to guide treatment decisions…
Trump Accelerates Psychedelic Drug Research to Aid Veterans
Federal policy changes are accelerating psychedelic drug research veterans to improve treatment timelines. This focus on veterans aims to bring MDMA and psilocybin therapies closer to clinical use. The research targets treatment-resistant PTSD and…
White House Advances Psychedelic Research for Veterans—Why Cannabis Could Benefit Next
The White House advances psychedelic research veterans benefits with new federal initiatives. This development highlights emerging clinical interest in psychedelic and cannabis therapies. Clinicians should monitor these advances for potential impacts on…
Missouri Bill Would Allow Clinical Trials on Psychedelic Therapy for Veterans, First Responders
Missouri's new bill enables psychedelic-assisted therapy clinical trials specifically for veterans and first responders. These clinical trials aim to generate rigorous safety and efficacy data. Psychedelic-assisted therapy clinical trials represent a…
Army Adopts New Cannabis Policy to Boost Recruitment (Newsletter: March 26, 2026)
The 2026 military cannabis policy changes mark a significant shift in army recruitment strategies. These changes affect veteran healthcare and civilian-military care transitions. Clinicians should monitor evolving policies to better serve military and…